Lin, L., Cai, J., Tan, Z., Meng, X., Li, R., Li, Y., & Jiang, C. (2021). Mutant IDH1 Enhances Temozolomide Sensitivity via Regulation of the ATM/CHK2 Pathway in Glioma. Cancer Res Treat.

Lin, Lin, Jinquan Cai, Zixiao Tan, Xiangqi Meng, Ruiyan Li, Yang Li, and Chuanlu Jiang. "Mutant IDH1 Enhances Temozolomide Sensitivity Via Regulation of the ATM/CHK2 Pathway in Glioma." Cancer Res Treat 2021.

Lin, Lin, et al. "Mutant IDH1 Enhances Temozolomide Sensitivity Via Regulation of the ATM/CHK2 Pathway in Glioma." Cancer Res Treat 2021.